ImageneBio, Inc. IMA
4.72
0.06
1.29%
as of 25 Sep
- Market cap
- $52.9M
- P/E
- 0.0×
Follow IMA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 9.62 | 9.62 | 9.62 | 11.32 | 6.07 | 9.06 | 3.20 | 5.47 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (7.04) | (7.04) | (7.04) | (26.24) | (5.37) | (3.80) | (6.76) | (4.66) |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 1.69 | 0.64 | 0.49 | 0.00 | 0.25 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 1.69 | 0.64 | 0.49 | 0.00 | 0.25 |
EV/Sales |
— | 0.54 | 0.54 | 0.54 | 6.43 | 1.19 | (1.10) | 13.30 | (2.50) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.32 |
EV/Operating CF |
— | (0.13) | (0.13) | (0.13) | (3.31) | (0.25) | 0.13 | (4.58) | 0.32 |
EV/FCF |
— | (0.13) | (0.13) | (0.13) | (3.21) | (0.25) | 0.13 | (4.80) | 0.33 |
Quick Ratio |
— | 4.75 | 3.38 | 5.74 | 8.54 | 7.30 | 12.35 | 0.70 | 12.05 |
Current Ratio |
— | 5.22 | 3.51 | 5.86 | 8.70 | 7.44 | 12.58 | 0.72 | 12.49 |
Net Debt/EBITDA |
— | (1.10) | 0.18 | 3.67 | 6.86 | 2.21 | 2.30 | 0.13 | 2.85 |
Debt/Assets |
0.00% | 302.65% | 91.73% | 0.11% | 0.75% | 1.11% | 0.00% | 47.10% | 0.00% |
Debt/Equity |
— | (1.37) | (1.28) | 0.00 | 0.01 | 0.01 | 0.00 | (0.05) | 0.00 |
Asset Turnover |
— | 0.10 | 0.26 | 0.07 | 0.15 | 0.07 | 0.05 | 0.03 | 0.01 |
Operating CF/Net income |
— | 0.28 | (2.85) | 0.85 | 1.77 | 1.08 | 1.17 | 0.44 | 0.91 |
Capex/Depreciation |
— | 0.00 | 0.00 | (2.55) | (3.24) | (1.79) | 0.41 | 0.64 | 0.00 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 76.17% | 31.34% | 54.47% | (63.87%) | (38.76%) | (43.04%) | 989.95% | 225.87% | |
| — | (395.29%) | (31.54%) | (34.80%) | (16.39%) | (32.73%) | (37.42%) | (46.52%) | (62.04%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | (242.49%) | (27.27%) | (31.83%) | (16.11%) | (48.52%) | (40.87%) | 1,166.44% | (40.60%) |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 3,895.35% | 180.44% | 487.79% | 152.03% | 411.84% | 651.22% | 917.40% | 3,565.63% |
Selling, General and Administrative Expense of Revenue |
— | 292.73% | 53.13% | 96.43% | 58.14% | 142.15% | 272.11% | 239.74% | 2,590.75% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 19.55% | 16.71% | 48.18% | 83.32% | 151.29% | 1,923.88% |
Graham Net Nets |
— | (1.17) | (1.17) | (1.17) | 0.56 | 1.42 | 1.88 | (6.98) | 3.58 |
Graham Number |
— | 0.00 | 0.00 | 1,377.29 | 0.00 | 0.00 | 0.00 | 322.63 | 0.00 |
Earnings Yield |
— | (50.04%) | (50.04%) | (50.04%) | (25.45%) | (72.93%) | (82.45%) | (156.33%) | (94.45%) |
Free Cash Flow Yield |
— | (43.64%) | (43.64%) | (43.64%) | (17.68%) | (79.70%) | (96.55%) | (86.59%) | (139.46%) |
Revenue per Share |
— | 0.03 | 0.38 | 39.92 | 13.29 | 5.18 | 2.63 | 2.93 | 0.16 |
Operating CF per Share |
— | (0.32) | 1.34 | (164.25) | (25.85) | (24.58) | (22.94) | (17.86) | (9.82) |
Capex per Share |
— | 0.00 | 0.00 | (3.33) | (0.75) | (0.47) | (0.12) | 0.81 | 0.00 |
Free Cash Flow per Share |
— | (0.32) | 1.34 | (167.57) | (26.60) | (25.06) | (23.06) | (17.04) | (9.82) |
Cash per Share |
— | 0.51 | 2.29 | 705.56 | 99.62 | 52.06 | 50.47 | 10.15 | 27.79 |
Shareholders Equity per Share |
— | (1.28) | (1.71) | (438.77) | 89.18 | 48.75 | 48.83 | (134.48) | 27.33 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (1.28) | (1.71) | (438.77) | 89.18 | 48.75 | 48.83 | (134.48) | 27.33 |
Free Cash Flow |
— | (11.61) | 47.93 | (38.59) | (62.01) | (75.54) | (80.16) | (20.35) | (47.84) |
Working Capital |
— | 16.16 | 60.91 | 137.64 | 209.33 | 138.51 | 164.46 | (4.74) | 129.05 |
Capital Expenditures |
— | (0.30) | (0.32) | (0.77) | (1.76) | (1.43) | (0.41) | 0.97 | — |
Net Current Asset Value |
— | (46.54) | (62.23) | (103.48) | 196.51 | 134.72 | 156.33 | (164.02) | 120.45 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.32 |
Capex to Sales |
— | 0.00 | 0.00 | 0.08 | 0.06 | 0.09 | 0.05 | (0.28) | 0.00 |
Net Profit Margin |
— | (4,127.78%) | (122.28%) | (481.36%) | (110.10%) | (440.29%) | (744.17%) | (1,382.40%) | (6,549.38%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.61 | 0.16 | 0.22 | 0.22 | 0.25 | (0.43) | 2.57 | 0.00 |
Cash ROIC |
— | (35.26%) | 47.40% | (63.64%) | (14.19%) | (25.28%) | (23.78%) | 15.55% | (17.82%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | — | — | — |
Average Payables |
— | 1.60 | 1.60 | 1.53 | 2.25 | 2.24 | 2.08 | 3.68 | 3.36 |
Average Assets |
— | 10.34 | 53.33 | 127.19 | 208.14 | 210.07 | 182.18 | 104.01 | 84.45 |
Average Common Equity |
— | (53.65) | (53.65) | (81.26) | 53.41 | 177.42 | 158.36 | (4.89) | (23.20) |
Columns are period end dates